Solar panels stretching to horizon represent the coming energy abundance

When Energy Cost Approaches Zero: The Society That Will Unfold (Part 1)

The Paradox We Face 🔄 The global energy market is trapped in a bizarre contradiction. Households and businesses suffer from rising energy prices and climate crisis anxiety. Yet behind the scenes, thousands of gigawatts of clean energy sit dormant—waiting for grid connection. In the United States alone, 2,600GW of new generation projects sit in interconnection queues. This isn’t an administrative delay. It’s a systemic market failure—an extraction-based paradigm unable to absorb creation-based technologies growing exponentially. ...

February 19, 2026 Â· 8 min Â· 1552 words Â· Den Kim
AI transforming biotech and drug discovery

The AI Biotech Survival Playbook: Lessons from AbCellera

🧬 The New Reality of AI Biotech Generative AI and DeepMind’s innovations have completely transformed the biotech industry. Looking at what small and mid-sized AI biotech companies like AbCellera Biologics are facing, the survival rules of the AI era become crystal clear. ⚡ The Perfect Storm Facing AbCellera 1. Big Pharma’s Direct Investment Rush In 2026, major pharmaceutical companies completely changed their AI investment strategy. Partnership Details Eli Lilly + Chai Discovery Multi-target biological drug design platform GSK + Noetik $50M upfront for cancer prognosis prediction foundation model Pfizer + Boltz Exclusive model development for small molecule discovery Big Pharma is now skipping the “middleman” and partnering directly with AI platforms. The space for mid-sized biotechs like AbCellera is rapidly shrinking. ...

February 15, 2026 Â· 4 min Â· 807 words Â· Den Kim